Market | Corporate Results

Neimeth International Pharmaceuticals Plc Reports N109.66m Loss in Q3'22 Unaudited Results, (SP:N1.38k)

Nov 23, 2022   •   by NGX   •   Source: NGX   •   eye-icon 107 views

Neimeth International Pharmaceuticals Plc released its Q3 2022 Unaudited results for the period ended September 30th, 2022.

Key Highlights

  • Revenue declined by 11.3% from N3.05bn to N2.70bn.
  • Loss before tax stood at N109.66m
  • Loss after tax stood at N109.66m
  • Share Price Currently Stands at N1.38k


Related items.

Get the App

apple-store  play-store

Connect with us

Proshare is a professional practice focused on delivering research and information services to bridge the gap between investors and markets; by delivery on credible, reliable, and timely engagements through the following areas — Impact Research, Market Intelligence, Strategic Advisory, Stakeholder Relations & Digital Media.